Literature DB >> 32645978

A National Survey of Companion Animal Owners' Self-Reported Methods of Coping Following Euthanasia.

Rachel Park1, Kenneth Royal1.   

Abstract

(1) Background: The human-animal bond is often regarded as a special relationship in which owners benefit from unconditional love and perceived understanding from their companion animal. Thus, end-of-life decisions such as euthanasia may inflict significant emotional impact upon the companion animal owner and result in a complicated grief response. The purpose of this study was to examine the methods American companion animal owners utilize to cope with loss following companion animal euthanasia. (2)
Methods: A total of 340 companion animal owners with experience euthanizing a companion animal completed an online survey asking how they found comfort after the loss of their companion animal. (3)
Results: A total of 74.7% noted that they mourned privately, 58.2% sought social support, 32.1% adopted a new companion animal, 12.4% relied on faith or prayer and 0.9% participated in a support group. (4) Conclusions: Grief associated with companion animal loss is important. As a majority of clients that euthanized their companion animal mourn privately, the veterinary community must work towards identifying and providing appropriate, accessible social resources for bereaved companion animal owners to utilize, if desired.

Entities:  

Keywords:  companion animal; coping; euthanasia; grief; human–animal interactions; pet bereavement; pet loss; survey

Year:  2020        PMID: 32645978     DOI: 10.3390/vetsci7030089

Source DB:  PubMed          Journal:  Vet Sci        ISSN: 2306-7381


  1 in total

1.  Preliminary Exploration of Weekly Peer Group Discussions as a Strategy for Coping with Feelings Associated with Euthanasia in Dairy Caretakers.

Authors:  Lily Edwards-Callaway; Hailey Simpson; Noa Román-Muñiz; Catie Cramer; Sage Mijares; Lorann Stallones; Jorge Rivera-Gonzalez; Jennifer Aberle
Journal:  Int J Environ Res Public Health       Date:  2022-02-15       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.